| Subscribe To Our Free Newsletter |
Cipla shares fall; traders cite FDA concerns over InvaGen plant
Cipla, India's fourth-largest drugmaker by sales, fell as much as 3 per cent to Rs 660 in early trade before recovering to Rs 670.70, still down 1.12 per cent or Rs 7.60.
Traders cited a...
